FERMENTABSEFermenta Biotech LtdMediumNeutral
Announced Tue, 1 Apr · 12:50 IST

Intimation about re-appointment of Independent Director

Management Changes View source PDF

FERMENTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Fermenta Biotech has re-appointed Ms. Rajashri Ojha (DIN: 07058128) as an Independent Director for a second consecutive term of 3 years, effective April 1, 2025. Her first term ended on March 31, 2025, and the re-appointment was approved by shareholders on December 26, 2024. Ms. Ojha brings around 35 years of experience in pharmaceuticals, nutraceuticals, medical devices, cosmetics, and food and veterinary industries, with expertise in global drug regulatory affairs, quality compliance, audits, and marketing approvals. She has also received the TOPRA-UK Award for Regulatory Excellence.

Likely market impact

This is a routine governance update with no material impact on shareholders or the stock price. Continuity on the board is maintained and the company retains regulatory expertise at the director level.